Inactive

Under a Project BioShield contract that was awarded in 2017, Bavarian Nordic has achieved the JYNNEOS© vaccine and it has been procured by the government. However more vaccine is needed to assist in t... Under a Project BioShield contract that was awarded in 2017, Bavarian Nordic has achieved the JYNNEOS© vaccine and it has been procured by the government. However more vaccine is needed to assist in the fight against the current outbreak and public health emergency regarding Monkeypox. The Government intends to negotiate solely with Bavarian Nordic, per FAR 6.302-1 as no other source will satisfy agency requirements. The procurement of vaccine against smallpox/monkeypox has been deemed important and essential in combatting the current outbreak of Monkeypox.